Literature DB >> 25696180

Pharmacological stress: a useful exercise?

E E van der Wall.   

Abstract

Year:  2003        PMID： 25696180      PMCID： PMC2499869     

Source DB:  PubMed          Journal:  Neth Heart J        ISSN： 1568-5888            Impact factor:   2.380


× No keyword cloud information.
  32 in total

1.  The adenosine saga: one more piece of the puzzle. But does it cause wall motion abnormalities?

Authors:  M S Verani
Journal:  Circulation       Date:  1992-09       Impact factor: 29.690

2.  Do stress echocardiography and myocardial perfusion imaging have the same ability to identify the low-risk patient with known or suspected coronary artery disease?

Authors:  K A Brown
Journal:  Am J Cardiol       Date:  1998-04-15       Impact factor: 2.778

3.  Prognostic value of pharmacological stress echocardiography in patients with known or suspected coronary artery disease: a prospective, large-scale, multicenter, head-to-head comparison between dipyridamole and dobutamine test. Echo-Persantine International Cooperative (EPIC) and Echo-Dobutamine International Cooperative (EDIC) Study Groups.

Authors:  A Pingitore; E Picano; A Varga; G Gigli; L Cortigiani; M Previtali; G Minardi; M Q Colosso; J Lowenstein; W Mathias; P Landi
Journal:  J Am Coll Cardiol       Date:  1999-11-15       Impact factor: 24.094

4.  Prediction of mortality using dobutamine echocardiography.

Authors:  T H Marwick; C Case; S Sawada; C Rimmerman; P Brenneman; R Kovacs; L Short; M Lauer
Journal:  J Am Coll Cardiol       Date:  2001-03-01       Impact factor: 24.094

5.  Cardiac imaging for risk stratification with dobutamine-atropine stress testing in patients with chest pain. Echocardiography, perfusion scintigraphy, or both?

Authors:  M L Geleijnse; A Elhendy; R T van Domburg; J H Cornel; R Rambaldi; A Salustri; A E Reijs; J R Roelandt; P M Fioretti
Journal:  Circulation       Date:  1997-07-01       Impact factor: 29.690

6.  Dipyridamole echocardiographic test performed 3 days after an acute myocardial infarction: feasibility, tolerability, safety and in-hospital prognostic value.

Authors:  F Chiarella; S Domenicucci; P Bellotti; P Bellone; G Scarsi; C Vecchio
Journal:  Eur Heart J       Date:  1994-06       Impact factor: 29.983

7.  Selection of the optimal nonexercise stress for the evaluation of ischemic regional myocardial dysfunction and malperfusion. Comparison of dobutamine and adenosine using echocardiography and 99mTc-MIBI single photon emission computed tomography.

Authors:  T Marwick; B Willemart; A M D'Hondt; T Baudhuin; W Wijns; J M Detry; J Melin
Journal:  Circulation       Date:  1993-02       Impact factor: 29.690

8.  Stress echocardiography: comparison of exercise, dipyridamole and dobutamine in detecting and predicting the extent of coronary artery disease.

Authors:  A Dagianti; M Penco; L Agati; S Sciomer; A Dagianti; S Rosanio; F Fedele
Journal:  J Am Coll Cardiol       Date:  1995-07       Impact factor: 24.094

9.  Dipyridamole thallium testing: noncardiac side effects, cardiac effects, electrocardiographic changes and hemodynamic changes after dipyridamole infusion with and without exercise.

Authors:  G J Laarman; M G Niemeyer; E E van der Wall; F J Verzijlbergen; T L Go; A V Bruschke; C A Ascoop
Journal:  Int J Cardiol       Date:  1988-08       Impact factor: 4.164

10.  Stress echocardiographic results predict risk of reinfarction early after uncomplicated acute myocardial infarction: large-scale multicenter study. Echo Persantine International Cooperative (EPIC) Study Group.

Authors:  E Picano; A Pingitore; R Sicari; G Minardi; N Gandolfo; G Seveso; F Chiarella; L Bolognese; G Chiaranda; M G Sclavo
Journal:  J Am Coll Cardiol       Date:  1995-10       Impact factor: 24.094
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.